Skip to main content
. 2021 Jan 13;4(1):e2033787. doi: 10.1001/jamanetworkopen.2020.33787

Table 2. Base Case Resultsa.

Variable Cost (95% CI), $ QALYs (95% CI)
37-mo Follow-up
ADT plus PRT 114.223 (95 809 to 132 636) 1.62 (1.55 to 1.69)
PRT 94 751 (79 476 to 110 025) 1.78 (1.70 to 1.86)
Net difference −19 472 (−16 333 to −22 611) 0.16 (0.15 to 0.17)
Lifetime follow-up
ADT plus PRT 328 971 (251 340 to 406 602) 2.22 (2.01 to 2.43)
PRT 298 741 (228 244 to 369 238) 3.03 (2.74 to 3.32)
Net difference −30 229 (−23 096 to −37 362) 0.81 (0.73 to 0.89)

Abbreviations: ADT, androgen deprivation therapy; PRT, prostate radiation therapy; QALYs, quality-adjusted life-years.

a

The 95% CIs were calculated with 10 000 individual trials.